Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. More Details
Flawless balance sheet and undervalued.
Share Price & News
How has Grand Brilliance Group Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 8372 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 8372's weekly volatility (7%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 8372 underperformed the Hong Kong Healthcare industry which returned 21.4% over the past year.
Return vs Market: 8372 underperformed the Hong Kong Market which returned 29.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Grand Brilliance Group Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StIs Now The Time To Put Grand Brilliance Group Holdings (HKG:8372) On Your Watchlist?
2 months ago | Simply Wall StWe're Watching These Trends At Grand Brilliance Group Holdings (HKG:8372)
3 months ago | Simply Wall StHave Grand Brilliance Group Holdings Limited (HKG:8372) Insiders Been Selling Their Stock?
Is Grand Brilliance Group Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 8372 (HK$0.08) is trading below our estimate of fair value (HK$0.37)
Significantly Below Fair Value: 8372 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 8372 is good value based on its PE Ratio (6.7x) compared to the HK Healthcare industry average (20.5x).
PE vs Market: 8372 is good value based on its PE Ratio (6.7x) compared to the Hong Kong market (11.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 8372's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 8372 is good value based on its PB Ratio (0.7x) compared to the HK Healthcare industry average (1.3x).
How is Grand Brilliance Group Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Grand Brilliance Group Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Grand Brilliance Group Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 8372 has high quality earnings.
Growing Profit Margin: 8372's current net profit margins (14.7%) are higher than last year (12.9%).
Past Earnings Growth Analysis
Earnings Trend: 8372's earnings have grown by 1.7% per year over the past 5 years.
Accelerating Growth: 8372's earnings growth over the past year (11.3%) exceeds its 5-year average (1.7% per year).
Earnings vs Industry: 8372 earnings growth over the past year (11.3%) exceeded the Healthcare industry 1%.
Return on Equity
High ROE: 8372's Return on Equity (10.3%) is considered low.
How is Grand Brilliance Group Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 8372's short term assets (HK$97.2M) exceed its short term liabilities (HK$14.1M).
Long Term Liabilities: 8372's short term assets (HK$97.2M) exceed its long term liabilities (HK$1.8M).
Debt to Equity History and Analysis
Debt Level: 8372 is debt free.
Reducing Debt: 8372 had no debt 5 years ago.
Debt Coverage: 8372 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 8372 has no debt, therefore coverage of interest payments is not a concern.
What is Grand Brilliance Group Holdings's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 8372's dividend (5.54%) is higher than the bottom 25% of dividend payers in the Hong Kong market (1.96%).
High Dividend: 8372's dividend (5.54%) is low compared to the top 25% of dividend payers in the Hong Kong market (5.97%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, 8372 has been paying a dividend for less than 10 years.
Growing Dividend: 8372's dividend payments have increased, but the company has only paid a dividend for 2 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (37.3%), 8372's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Bikie Wong (51 yo)
Ms. Bik-Kwan Wong, also known as Bikie, has been Chairman and Chief Executive Officer at Grand Brilliance Group Holdings Limited March 1, 2018 and has been its Executive Director since September 18, 2017. ...
CEO Compensation Analysis
Compensation vs Market: Bikie's total compensation ($USD568.34K) is above average for companies of similar size in the Hong Kong market ($USD230.00K).
Compensation vs Earnings: Bikie's compensation has increased by more than 20% in the past year.
Experienced Management: 8372's management team is considered experienced (4.6 years average tenure).
Experienced Board: 8372's board of directors are considered experienced (3.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Grand Brilliance Group Holdings Limited's company bio, employee growth, exchange listings and data sources
- Name: Grand Brilliance Group Holdings Limited
- Ticker: 8372
- Exchange: SEHK
- Founded: 1998
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: HK$63.200m
- Shares outstanding: 800.00m
- Website: https://www.grandbrilliancegroup.com
Number of Employees
- Grand Brilliance Group Holdings Limited
- The Octagon
- 29th Floor
- Tsuen Wan
- New Territories
- Hong Kong
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. The company offers medical consumables; medical instruments; and medical equipm...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/10 10:35|
|End of Day Share Price||2021/04/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.